Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Double homeobox 4 like 13 (DUX4L13) is a human pseudogene related to the double homeobox 4 (DUX4) gene, which encodes a transcription factor containing two homeodomains and plays key roles in early embryonic gene regulation and in several disease processes when aberrantly expressed. DUX4L13 itself, however, is not known to be expressed or translated into a functional protein, and there is no evidence implicating DUX4L13 in disease, biological processes, or as a therapeutic target[1]. Most scientific and clinical literature involving "double homeobox 4" refers to the DUX4 gene, not DUX4L13, so claims or experimental findings concerning DUX4 should not be attributed to DUX4L13[1][5]. If considering drug targeting, disease relevance, or biological function, DUX4 (not DUX4L13) is the molecule of interest[3][5]. DUX4L13 remains a non-coding pseudogene with no currently recognized clinical or experimental significance.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Double homeobox 4 like 13 (DUX4L13).